One of Africa's rarest primates protected by... speedbumps
(Press-News.org) ZANZIBAR CITY (April 7, 2021) - A new study revealed that a drastic reduction of deaths of one of Africa's rarest primates, the Zanzibar red colobus (Piliocolobus kirkii), followed the installation of four speedbumps along a stretch of road where the species frequently crossed.
Zanzibar red colobus are found only in the Zanzibar archipelago and classified as Endangered by the IUCN Red List. Reliant on Unguja Island's forests for their survival, around half of the species population is found in Jozani-Chwaka Bay National Park.
In the study, published in Oryx - The International Journal of Conservation, primatologists from Bangor University, in collaboration with national park managers from Zanzibar and the Wildlife Conservation Society (WCS), assessed mortality from vehicle collisions - a growing threat faced by primates living in increasingly fragmented habitats crisscrossed by roads.
They found that historic data from the road traversing the national park showed that one colobus was killed on average every 2-3 weeks by traffic. After speedbumps were installed, this was reduced to one every six weeks.
While great progress, this mortality rate is still a significant threat to the species - especially given that natural predation tends to target weaker individuals, yet roadkill is indiscriminate, killing reproductively active adults as well as the very young and old.
Bangor primatologist and Director of the Zanzibar Red Colobus Project, Dr. Alexander Georgiev, and senior author of this study, said: "Cars are not selective in the animals they kill. This means that while natural predators may target the very young and old more often, cars are equally likely to kill reproductively active young adults, who would contribute the most to population growth. And this may be a problem."
Harry Olgun, now a PhD student at the University's School of Natural Sciences, led this study as part of his Masters research on the road ecology of the Zanzibar red colobus. Olgun said: "After the road at Jozani was surfaced but before the speedbumps were installed, a colobus was reported to have been killed every two to three weeks, resulting in perhaps about 12-17 percent annual mortality, according to one estimate. The recent data show that speedbumps have made a huge difference for the safety of the colobus. Adding more speedbumps would help reduce the risk further."
Dr. Tim Davenport, Director of Species Conservation & Science in Africa at WCS, who led the first countrywide census of the Zanzibar red colobus a few years ago and is a coauthor of the study, said: "As tourism grows in Zanzibar and habitat continues to shrink, using science to quantify and solve conservation problems has never been so important. Understanding the impact of vehicles on wildlife within a park, and implementing practical solutions is exactly what we as conservationists should be doing."
WCS (Wildlife Conservation Society)
MISSION: WCS saves wildlife and wild places worldwide through science, conservation action, education, and inspiring people to value nature. To achieve our mission, WCS, based at the Bronx Zoo, harnesses the power of its Global Conservation Program in nearly 60 nations and in all the world's oceans and its five wildlife parks in New York City, visited by 4 million people annually. WCS combines its expertise in the field, zoos, and aquarium to achieve its conservation mission. Visit: newsroom.wcs.org Follow: @WCSNewsroom. For more information: 347-840-1242.
ELSE PRESS RELEASES FROM THIS DATE:
Eight months after mild COVID-19, one in ten people still has at least one moderate to severe symptom that is perceived as having a negative impact on their work, social or home life. The most common long-term symptoms are a loss of smell and taste and fatigue. This is according to a study published in the journal JAMA, conducted by researchers at Danderyd Hospital and Karolinska Institutet in Sweden.
Since spring 2020, researchers at Danderyd Hospital and Karolinska Institutet have conducted the so-called COMMUNITY study, with the main purpose of examining immunity after COVID-19. In the first phase of the study in spring 2020, blood samples were collected from 2,149 employees at Danderyd Hospital, of whom about 19 percent had antibodies against SARS-CoV-2. Blood samples have since ...
With a lethal, airborne virus spreading fast, hospitals had to change how they treated patients and policies for how caregivers provided that treatment. But for maternity patients and nurses some of those changes had negative outcomes, according to a new University of Washington study.
"We found that visitor restrictions and separation policies were harming families and nurses. The effects for patients included loneliness, isolation and mistrust, while nurses described mistrust and low morale," said Molly Altman, lead author of the study and assistant professor in the UW School of Nursing.
Importantly, Altman added, both nurses and patients described how COVID "amplified existing ...
LA JOLLA--(April 7, 2021) When cells are stressed, chemical alarms go off, setting in motion a flurry of activity that protects the cell's most important players. During the rush, a protein called Parkin hurries to protect the mitochondria, the power stations that generate energy for the cell. Now Salk researchers have discovered a direct link between a master sensor of cell stress and Parkin itself. The same pathway is also tied to type 2 diabetes and cancer, which could open a new avenue for treating all three diseases.
"Our findings represent the earliest step in Parkin's alarm response that anyone's ever found by a long shot. ...
New medicines for people who have diabetes seem to pop up all the time. Drugs that help the body break down carbohydrates, drugs that increase excretion of glucose in the urine, drugs that help muscles respond to insulin and drugs that stimulate the pancreas to produce it -- the list of pharmaceutical options to treat diabetes gets longer and longer.
The downside of this wealth of treatment options is that it can be difficult for health care providers to stay on top of the latest research and standards of care. Which medication is best for which patients? And what are the best medicines to prescribe that both lower blood glucose and reduce risk for cardiovascular disease?
Johns Hopkins Medicine endocrinologist ...
How many species of birds are there in the world? It depends on whose count you go by. The number could be as low as 10,000 or as high as 18,000. It's tough to standardize lists of species because the concept of a "species" itself is a little bit fuzzy.
That matters because conserving biodiversity requires knowing what diversity exists in the first place. So biologists, led by University of Utah doctoral candidate Monte Neate-Clegg of the School of Biological Sciences, set out to compare four main lists of bird species worldwide to find out how the lists differ--and why. They found that although the lists agree on most birds, disagreements in some regions ...
A new analysis of lung epithelial cells from COVID-19 patients reveals how the protective complement branch of the immune system, which usually plays roles in both innate and adaptive immunity, can convert to a harmful system during COVID-19. Blocking excessive complement activity in lung epithelial cells with a combination of existing chemotherapy and antiviral medications - ruxolitinib and remdesivir, respectively - helped normalize the production of complement proteins by infected lung epithelial cells in human cell culture experiments, the researchers found. Thus, the drug duo could serve as a promising strategy to treat damaging inflammation during severe COVID-19, the authors say. Overactivation of complement proteins can contribute to diseases such as acute respiratory distress ...
HERSHEY, Pa.-- Social distancing and lockdowns may have reduced the spread of COVID-19, but researchers from Penn State College of Medicine also report those actions may have affected clinical researchers' ability to finish trials. Study completion rates dropped worldwide between 13% and 23%, depending on the type of research sponsor and geographic location, between April and October 2020.
Researchers previously reported that more than 80% of clinical trials suspended between March 1 and April 26, 2020, noted the pandemic as their chief reason for halting activity. Patient enrollment in studies was lower in April 2020, compared to April ...
WYOMISSING, Pa. -- Teaching people to become entrepreneurs requires more than just passing on entrepreneurial skills, according to a team of Penn State Berks-led researchers. Would-be entrepreneurs also need to understand -- and negotiate -- the barriers that they might face.
In a study, researchers built a multidimensional model to measure the effectiveness of entrepreneurship education. The model not only includes teaching entrepreneurial skills, but also addresses the students' intentions to start a business and their perceptions of the barriers they might encounter when starting a business.
"There are a lot of studies in the literature that focus on, for example, how entrepreneurship education ...
HOUSTON -- (April 7, 2021) -- Rice University computer scientists have demonstrated artificial intelligence (AI) software that runs on commodity processors and trains deep neural networks 15 times faster than platforms based on graphics processors.
"The cost of training is the actual bottleneck in AI," said Anshumali Shrivastava, an assistant professor of computer science at Rice's Brown School of Engineering. "Companies are spending millions of dollars a week just to train and fine-tune their AI workloads."
Shrivastava and collaborators from Rice and Intel will present research that addresses that bottleneck April 8 at the machine learning systems conference MLSys.
Deep neural networks ...
In an article published in the April 8 issue of Nature, the National Institutes of Health's Somatic Cell Gene Editing Consortium provided a detailed update on the progress of their nationwide effort to develop safer and more effective methods to edit the genomes of disease-relevant somatic cells and reduce the burden of disease caused by genetic changes.
Gene editing allows scientists to modify sections of an organism's DNA and is considered a promising treatment for a number of genetic diseases. There have been numerous advances in the laboratory over the last few decades, but there are still many challenges to overcome before gene editing can be widely used in the patient population. Launched in 2018, the Somatic Cell Gene Editing Consortium ...
LAST 30 PRESS RELEASES:
[Press-News.org] One of Africa's rarest primates protected by... speedbumps